278 related articles for article (PubMed ID: 31176377)
21. Prospective analysis of gait characteristics in chronic inflammatory demyelinating polyradiculoneuropathy.
Bozovic I; Peric S; Basta I; Rakocevic-Stojanovic V; Lavrnic D; Stevic Z; Radovanovic S
J Clin Neurosci; 2020 Oct; 80():6-10. PubMed ID: 33099368
[TBL] [Abstract][Full Text] [Related]
22. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA;
Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948
[TBL] [Abstract][Full Text] [Related]
23. The effect of tremor on disability assessment in chronic inflammatory demyelinating polyradiculoneuropathy.
van Veen R; Pallada G; Wieske L; Ten Holter SEM; van Rootselaar AF; Verhamme C; de Bie RMA; van Schaik IN; Merkies ISJ; Dijk JM; Eftimov F
J Peripher Nerv Syst; 2023 Mar; 28(1):58-68. PubMed ID: 36571466
[TBL] [Abstract][Full Text] [Related]
24. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg.
Caro XJ; Winter EF; Dumas AJ
Rheumatology (Oxford); 2008 Feb; 47(2):208-11. PubMed ID: 18208823
[TBL] [Abstract][Full Text] [Related]
25. Elevated serum levels of endothelin-1 in patients with chronic inflammatory demyelinating polyneuropathy.
Chang CW; Wu HC; Lyu RK; Lo YS; Chen CM; Ro LS; Chang HS; Huang CC; Liao MF; Wu YR; Kuo HC; Chu CC; Weng YC; Wei PT; Lo AL; Chang KH
Clin Chim Acta; 2018 Jan; 476():49-53. PubMed ID: 29137897
[TBL] [Abstract][Full Text] [Related]
26. Development of weakness in patients with chronic inflammatory demyelinating polyneuropathy and only sensory symptoms at presentation: a long-term follow-up study.
van Dijk GW; Notermans NC; Franssen H; Wokke JH
J Neurol; 1999 Dec; 246(12):1134-9. PubMed ID: 10653304
[TBL] [Abstract][Full Text] [Related]
27. Does grip strength reflect isokinetic muscle strength in lower limbs in patients with chronic inflammatory demyelinating polyneuropathy?
Knak KL; Andersen LK; Christiansen I; Markvardsen LK
Muscle Nerve; 2018 Sep; 58(3):449-452. PubMed ID: 29603302
[TBL] [Abstract][Full Text] [Related]
28. Employment status of patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Bjelica B; Basta I; Bozovic I; Kacar A; Nikolic A; Dominovic-Kovacevic A; Vukojevic Z; Martic V; Stojanov A; Djordjevic G; Petrovic M; Stojanovic M; Peric S
J Peripher Nerv Syst; 2018 Sep; 23(3):178-182. PubMed ID: 29999199
[TBL] [Abstract][Full Text] [Related]
29. Symptoms of activity-induced weakness in peripheral nervous system disorders.
Straver DC; van den Berg LH; van Doorn PA; Franssen H
J Peripher Nerv Syst; 2011 Jun; 16(2):108-12. PubMed ID: 21692909
[TBL] [Abstract][Full Text] [Related]
30. Chronic Acquired Polyneuropathy Patient Reported Index (CAPPRI) in chronic inflammatory demyelinating polyradiculoneuropathy.
Bjelica B; Peric S; Gwathmey K; Sadjadi R; Bozovic I; Burns TM; Basta I
J Peripher Nerv Syst; 2019 Sep; 24(3):247-252. PubMed ID: 31209940
[TBL] [Abstract][Full Text] [Related]
31. Atypical childhood chronic inflammatory demyelinating polyneuropathy.
Mohamed AR; Rodriguez-Casero MV; Ryan MM
Muscle Nerve; 2010 Aug; 42(2):293-5. PubMed ID: 20589891
[TBL] [Abstract][Full Text] [Related]
32. Restless legs syndrome in chronic inflammatory demyelinating polyneuropathy.
Rajabally YA; Shah RS
Muscle Nerve; 2010 Aug; 42(2):252-6. PubMed ID: 20544936
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics, and impairment and disability scale scores for different CIDP Disease Activity Status classes.
Alabdali M; Abraham A; Alsulaiman A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
J Neurol Sci; 2017 Jan; 372():223-227. PubMed ID: 28017218
[TBL] [Abstract][Full Text] [Related]
34. Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP.
Staudt M; Diederich JM; Meisel C; Meisel A; Klehmet J
BMC Neurol; 2017 Apr; 17(1):81. PubMed ID: 28446142
[TBL] [Abstract][Full Text] [Related]
35. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
[TBL] [Abstract][Full Text] [Related]
36. Axonal loss in patients with inflammatory demyelinating polyneuropathy as determined by motor unit number estimation and MUNIX.
Paramanathan S; Tankisi H; Andersen H; Fuglsang-Frederiksen A
Clin Neurophysiol; 2016 Jan; 127(1):898-904. PubMed ID: 26049677
[TBL] [Abstract][Full Text] [Related]
37. Short-term and long-term effects of immunoadsorption in refractory chronic inflammatory demyelinating polyneuropathy: a prospective study in 17 patients.
Dorst J; Ludolph AC; Senel M; Tumani H
J Neurol; 2018 Dec; 265(12):2906-2915. PubMed ID: 30293110
[TBL] [Abstract][Full Text] [Related]
38. Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy.
Dionne A; Nicolle MW; Hahn AF
Muscle Nerve; 2010 Feb; 41(2):202-7. PubMed ID: 19882646
[TBL] [Abstract][Full Text] [Related]
39. Misdiagnosis and diagnostic pitfalls of chronic inflammatory demyelinating polyradiculoneuropathy.
Broers MC; Bunschoten C; Drenthen J; Beck TAO; Brusse E; Lingsma HF; Allen JA; Lewis RA; van Doorn PA; Jacobs BC
Eur J Neurol; 2021 Jun; 28(6):2065-2073. PubMed ID: 33657260
[TBL] [Abstract][Full Text] [Related]
40. Predicting long-term trends in inflammatory neuropathy outcome measures using latent class modelling.
Keh RYS; Selby DA; Jones S; Gosal D; Lavin T; Lilleker JB; Carr AS; Lunn MP
J Peripher Nerv Syst; 2022 Mar; 27(1):84-93. PubMed ID: 34936164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
